The APV board
The APV board is elected every four years by the general assembly of members. It consists of up to eight experts from industry and academia. The board actively supports the specialist groups, in addition to its statutory functions.
President
Prof. Dr. Sandra Klein
Institut für Pharmazie
Biopharmazie und Pharmazeutische Technologie
Universität Greifswald
Felix-Hausdorff-Strasse 3
D-17489 Greifswald
Sandra.Klein@uni-greifswald.de
Vice-President
Prof. Dr. Jörg Breitkreutz
Institut für Pharmazeutische Technologie
Heinrich-Heine-Universität Düsseldorf Geb. 26.22
Universitätstr. 1
D-40225 Düsseldorf
joerg.breitkreutz@uni-duesseldorf.de
Treasurer
Dr. Karoline Bechtold-Peters
Novartis Pharma AG
4002 Basel
Werk Klybeck
Switzerland
Secretary
Dr. Alena Wieber
Merck Life Science KGaA
Frankfurter Str. 250
64293 Darmstadt, Germany
Member of executive council
Prof. Dr. Johannes Bartholomäus
TU Braunschweig and Pharmakreativ Pharmaceutical Development Consulting
Burghöhenweg 5
52080 Aachen, Germany
Member of executive council
Dr. Kathrin Bartscher
NextPharma
Im Wirrigen 25
D-45731 Waltrop
Kathrin.bartscher@nextpharma.com
Member of executive council
Dr. Martin Lück
Grünenthal GmbH
Zieglerstraße 6
52078 Aachen, Germany
martin.lueck@grunenthal.com
Member of executive council
Dr. Florian Unger
Bayer AG
Friedrich-Ebert-Str. 217
42117 Wuppertal, Germany
florian.unger@bayer.com